.

Make Better Decisions

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Johnson and Johnson
US Army
Covington
Boehringer Ingelheim
UBS
Deloitte
Fuji
Merck
Medtronic
Citi

Generated: September 26, 2017

DrugPatentWatch Database Preview

Entacapone - Generic Drug Details

« Back to Dashboard

What are the generic sources for entacapone and what is the scope of entacapone patent protection?

Entacapone
is the generic ingredient in two branded drugs marketed by Macleods Pharms Ltd, Aurobindo Pharma Ltd, Wockhardt Ltd, Sun Pharma Global, Ajanta Pharma Ltd, Mylan Pharms Inc, and Orion Pharma, and is included in seven NDAs. There is one patent protecting this compound and one Paragraph IV challenge. Additional information is available in the individual branded drug profile pages.

Entacapone has forty-five patent family members in thirty-seven countries.

There are nineteen drug master file entries for entacapone. Seventeen suppliers are listed for this compound.

Summary for Generic Name: entacapone

Tradenames:2
Patents:1
Applicants:7
NDAs:7
Drug Master File Entries: see list19
Suppliers / Packagers: see list17
Bulk Api Vendors: see list44
Clinical Trials: see list40
Patent Applications: see list4,120
Therapeutic Class:Antiparkinson Agents
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:entacapone at DailyMed

Pharmacology for Ingredient: entacapone

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Mylan Pharms Inc
ENTACAPONE
entacapone
TABLET;ORAL202394-001May 13, 2013DISCNNoNo► Subscribe► Subscribe► Subscribe
Ajanta Pharma Ltd
ENTACAPONE
entacapone
TABLET;ORAL205792-001Aug 31, 2017ABRXNoNo► Subscribe► Subscribe► Subscribe
Macleods Pharms Ltd
ENTACAPONE
entacapone
TABLET;ORAL207210-001Jun 5, 2017ABRXNoNo► Subscribe► Subscribe► Subscribe
Wockhardt Ltd
ENTACAPONE
entacapone
TABLET;ORAL078941-001Aug 16, 2012ABRXNoNo► Subscribe► Subscribe► Subscribe
Orion Pharma
COMTAN
entacapone
TABLET;ORAL020796-001Oct 19, 1999ABRXYesYes► Subscribe► SubscribeY ► Subscribe
Aurobindo Pharma Ltd
ENTACAPONE
entacapone
TABLET;ORAL203437-001Jun 19, 2015ABRXNoNo► Subscribe► Subscribe► Subscribe
Sun Pharma Global
ENTACAPONE
entacapone
TABLET;ORAL090690-001Jul 16, 2012ABRXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: entacapone

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Orion Pharma
COMTAN
entacapone
TABLET;ORAL020796-001Oct 19, 1999► Subscribe► Subscribe
Orion Pharma
COMTAN
entacapone
TABLET;ORAL020796-001Oct 19, 1999► Subscribe► Subscribe
Orion Pharma
COMTAN
entacapone
TABLET;ORAL020796-001Oct 19, 1999► Subscribe► Subscribe
Orion Pharma
COMTAN
entacapone
TABLET;ORAL020796-001Oct 19, 1999► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Ingredient: entacapone

Country Document Number Estimated Expiration
Bulgaria65041► Subscribe
Peru10602000► Subscribe
Serbia49723► Subscribe
World Intellectual Property Organization (WIPO)0015196► Subscribe
Slovakia3072001► Subscribe
Denmark1112065► Subscribe
Poland193454► Subscribe
Colombia5130008► Subscribe
Hungary0103454► Subscribe
China1151778► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Dow
Medtronic
US Army
Colorcon
Federal Trade Commission
Novartis
Daiichi Sankyo
McKesson
Deloitte
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot